P. Schoenfeld Asset Management (PSAM)’s InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant IPVF.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IPVF.U
GCL
AC
AIMCA
KC
HP
PC
BCM
P. Schoenfeld Asset Management (PSAM)'s IPVF.U Position: Q2 2021 in Review
P. Schoenfeld Asset Management (PSAM) sold out of InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant (IPVF.U) in Q2 2021, closing a stake of 600,000 shares — an estimated $5.92M sold.
P. Schoenfeld Asset Management (PSAM) first reported a position in IPVF.U in Q1 2021 and held it in 1 quarter. The position peaked at $5.92M in Q1 2021. 39 funds tracked by Wall St. Rank hold IPVF.U as of Q2 2021.
- P. Schoenfeld Asset Management (PSAM) reported no remaining InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
- P. Schoenfeld Asset Management (PSAM) sold 600,000 InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant shares in Q2 2021, an estimated $5.92M.
- P. Schoenfeld Asset Management (PSAM) first reported a position in InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant in Q1 2021 and held it in 1 quarter.
- P. Schoenfeld Asset Management (PSAM)'s InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant position peaked at $5.92M in Q1 2021.
- 39 funds tracked by Wall St. Rank held InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant as of Q2 2021.
Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2021, filed 12 Aug 2021.